Ludo Reynders, PhD, Chief Executive Officer
In October 2010, Ludo Reynders joined Premier Research as Chief Executive Officer. Prior to joining the company, Ludo held a number of senior management positions in the CRO and pharmaceutical industry. As the CEO at AAIPharma, he led the reorganization of the company from a specialty pharmaceutical business to a full service development services company and its subsequent divestiture. As its President of European operations and as CEO of the CRO business at Quintiles, he was instrumental in the international growth and development of the company’s CRO business, initially in the UK and Europe, subsequently on a global basis. At Bristol Myers, he was a key member of the team that developed the company’s European clinical development footprint. Ludo holds Ph.D. and MS degrees in the Applied Biological Sciences from the University of Leuven, Belgium.